Please try another search
NexImmune, Inc. is a clinical-stage biotechnology company. The Company is engaged in developing an approach to immunotherapy designed to employ the body’s own T cells to generate an immune response that mimics natural biology. Its product candidates include NEXI-001 in acute myeloid leukemia (AML) and NEXI-002 in multiple myeloma (MM). The Company provides Artificial Immune Modulation (AIM), which is a nanoparticle technology platform. Its AIM technology enables it to construct nanoparticles that function as synthetic dendritic cells capable of directing a specific T cell-mediated immune response. The AIM nanoparticles employ signaling proteins to deliver instructions to T cells directing a desired immune response. The Company’s T cell product candidates are designed to combine the attributes of cellular with reduced potential for toxicities. It is also developing new AIM nanoparticle constructs and modalities for clinical evaluation in oncology and autoimmune disorders.
Name | Age | Since | Title |
---|---|---|---|
Sol J. Barer | 74 | 2019 | Independent Chairman of the Board |
Kristi Jones | 59 | 2017 | CEO, President & Director |
Paul D’Angio | 63 | 2017 | Independent Director |
Grant L. Verstandig | 32 | 2021 | Independent Director |
Paul Richardson | - | - | Member of Scientific Advisory Board |
Andreas Mackensen | - | 2021 | Member of Scientific Advisory Board |
Miguel-Angel Perales | - | 2021 | Member of Scientific Advisory Board |
Yi Lin | - | 2021 | Member of Scientific Advisory Board |
Kevan Herold | - | 2021 | Member of Scientific Advisory Board and Autoimmune & Infectious Disease Scientific Advisory Board |
Michelle Krogsgaard | - | 2021 | Member of Scientific Advisory Board |
David A. Hafler | - | 2022 | Member of Autoimmune & Infectious Disease Scientific Advisory Board |
Zhengbin Yao | 56 | 2017 | Independent Director |
Robert Siliciano | - | 2022 | Member of Autoimmune & Infectious Disease Scientific Advisory Board |
Marcela V. Maus | 45 | 2021 | Member of Scientific Advisory Board |
Robin A. Robinson | 65 | 2022 | Member of Autoimmune & Infectious Disease Scientific Advisory Board |
David Samuel diCapua Siegel | - | 2021 | Member of Scientific Advisory Board |
James G. Krueger | - | 2022 | Member of Autoimmune & Infectious Disease Scientific Advisory Board |
Juan Varela | - | 2021 | Member of Scientific Advisory Board |
Anil K. Rustgi | - | 2021 | Member of Scientific Advisory Board |
Gerald T. Nepom | - | 2022 | Chair of Autoimmune & Infectious Disease Scientific Advisory Board |
Timothy A. Bertram | 68 | 2017 | Independent Director |
Alan S. Roemer | 53 | 2017 | Independent Director |
Jonathan Schneck | - | 2012 | Co-Chairman of Scientific Advisory Board |
Jeffrey S. Weber | - | 2021 | Chief Scientific Advisor, Co-Chairman of Scientific Advisory Board and Member of AI & ID SAB |
Leena Gandhi | 52 | 2022 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review